1up Health is revolutionizing healthcare interoperability through its modern data platform, which enables secure and compliant exchange of health data. The company offers a suite of products including the 1up FHIR Platform, 1up Patient Connect, and 1up Analyze, designed to facilitate data aggregation, integration, and analytics for payers, providers, and life sciences. With over 80 enterprise customers, 1up Health stands out for its unparalleled expertise in FHIR APIs and its commitment to meeting CMS interoperability requirements. The platform's cloud-based architecture allows for flexible data ingestion and superior data quality controls, making it a leader in the healthcare data management space.
Adcentrx Therapeutics is a clinical-stage biotechnology company focused on accelerating breakthroughs in developing protein conjugate therapeutics for cancer and other life-threatening diseases. The company aims to create next-generation targeted therapies that combine the precision of biologics with the efficacy of small molecule payloads, addressing significant unmet medical needs in oncology. With a strong pipeline and recent FDA clearances for investigational drugs, Adcentrx is positioned to make a meaningful impact in the treatment landscape for advanced solid tumors.
Adela is pioneering advanced technology for cancer detection through blood tests, focusing on minimal residual disease (MRD) testing and early cancer identification. Their patented cf Me DIP-seq platform enhances test performance by capturing extensive genomic information, making it applicable across various cancers. With a mission to improve cancer care, Adela's innovative approach is set to transform treatment decisions and patient outcomes, positioning them as a leader in the oncology diagnostics market.
Affinia Therapeutics is a pioneering company in gene therapy, focusing on developing innovative adeno-associated virus (AAV) vectors to treat rare and prevalent diseases. Utilizing their proprietary ART (Affinia Rationally-designed Therapies) platform, they leverage AI and structural modeling to enhance the targeting and effectiveness of gene therapies, particularly for heart and nervous system diseases. With a team experienced in drug development and a commitment to patient-centered solutions, Affinia aims to set a new standard in gene therapy, expanding its reach to address significant unmet medical needs.
Albert Invent is a cloud-based end-to-end R&D platform designed for the materials science industry, empowering thousands of scientists across 30+ countries to expedite innovation. The platform integrates electronic lab notebooks (ELN), laboratory information management systems (LIMS), and AI tools to enhance collaboration, data management, and regulatory compliance. With a focus on sustainability and customer success, Albert Invent aims to revolutionize chemical research by providing a unified solution that accelerates product development and reduces inefficiencies in R&D processes.
Amber Therapeutics is pioneering the first adaptive neuromodulation therapy for women suffering from mixed urinary incontinence. Their flagship product, the Picostim TM System, is a fully implantable device that targets the pudendal nerve, providing personalized treatment by dynamically adapting to the patient's physiological responses. With a significant market need—40 million women in the US affected by urinary incontinence and only 16 million receiving therapy—Amber's innovative approach addresses both urge and stress incontinence, setting it apart from existing therapies. The company has demonstrated promising results in its AURA-2 study, showcasing safety and efficacy, and aims to transform the quality of life for millions of women globally.
Amplify MD is a leading virtual care solution for hospitals, providing integrated virtual care across specialties and care settings. Their platform enhances efficiency, making providers up to 2X more effective, while offering access to a built-in network of specialists in over 15 fields. The company addresses critical gaps in specialty coverage, enabling hospitals to manage telehealth services seamlessly across multiple EHRs. With a focus on improving clinical and financial outcomes, Amplify MD has demonstrated significant results, including a reduction in patient transfers and readmission rates, positioning itself as a key player in the virtual care market.
Argyle is the payroll connectivity platform for modern financial services. We provide fast, cost-effective, consumer-permissioned access to the most trusted network for real-time income and employment data. With Argyle, businesses automate verifications and background checks, fund accounts, switch direct deposits, calculate premiums, advance wages, and build more exceptional experiences for their customers. Founded in 2018, Argyle’s coverage of U.S. consumers is superior to the three largest credit bureaus and delivers hit rates 4 to 5 times higher than all other data providers at a fraction of the cost.